Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma

Incorporating miRNA expression in primary melanomas may enhance the accuracy of clinical prognostic models and potentially aid in the selection of patients with melanoma for adjuvant treatment and clinical trials.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-10-20
DOI
https://doi.org/10.1158/1078-0432.ccr-24-3785
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma

Tawny W. Boyce, Jennifer Wiggins, Paul B. Googe, James S. Wilmott et al.
Clinical Cancer Research
MicroRNA in disease regulation
article

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma

Tawny W. Boyce, Jennifer Wiggins, Paul B. Googe, James S. Wilmott, Eva Hernando, Adam Z. Reynolds, Caroline E. Kostrzewa, Li Luo, Meg R. Gerstenblith, David W. Ollila, Anne Elizabeth Cust, Jeffrey E. Lee, Yian Zhang, Klaus J. Busam, Christopher Ian Amos, Keimya Sadeghi, Kathleen Conway, Douglas Hanniford, Venkatraman Seshan, Ivan Gorlov, Nancy E. Thomas, Shaofeng Yan, Pei Fen Kuan, Ronglai Shen, Pauline Funchain, Marianne Berwick, Sheri L. Holmen, Bonnie E. Gould Rothberg, Allison Reiner, Eduardo Nagore, David Polsky, Irene Orlow, Yuting Lu, Judy R. Rees, Paul N. Bogner, Marcus Bosenberg, Yvonne M. Saenger, Colin B. Begg, Cheryl L. Thompson, Jennifer S. Ko, Yongzhao Shao, Cecilia Lezcano, Iman Osman, Jessica Kenney, Elise K. Brunsgaard, Richard A. Scolyer, Tim K. Lee, Sharon N. Edmiston, Graham J. Mann, Marc S. Ernstoff, Diana Argibay, Qiao Zhang, Linchen He, Fatemeh Vand-Rajabpour
article en

Abstract

Incorporating miRNA expression in primary melanomas may enhance the accuracy of clinical prognostic models and potentially aid in the selection of patients with melanoma for adjuvant treatment and clinical trials.

Clinical Cancer ResearchVol. 31(24)
Dartmouth College (US), University of North Carolina at Chapel Hill (US), Australian National University (AU), Rush University Medical Center (US), Dartmouth–Hitchcock Medical Center (US), Roswell Park Comprehensive Cancer Center (US), The University of Sydney (AU), Albert Einstein College of Medicine (US), Cleveland Clinic (US), Feinstein Institute for Medical Research (US), Memorial Sloan Kettering Cancer Center (US), Texas Medical Center (US), The University of Texas MD Anderson Cancer Center (US), University of Miami (US), University of New Mexico (US), Baylor College of Medicine (US), University of Utah (US), Columbia University Irving Medical Center (US), Royal Prince Alfred Hospital (AU), Huntsman Cancer Institute (US), Yale University (US), NYU Langone Health (US), University of Miami Health System (US), Fundación Instituto Valenciano de Oncología (ES), Victorian Comprehensive Cancer Centre (AU), Melanoma Institute Australia (AU), Dartmouth Psychiatric Research Center (US), National Cancer Institute (US), New Mexico Cancer Center (US), Canadian Centre for Applied Research in Cancer Control (CA), New York University (US), Case Western Reserve University (US), Stony Brook University (US), Penn State Milton S. Hershey Medical Center (US), Cancer Council NSW (AU), Stanford University (US)
Openalex Percentile: Top 64%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.